Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply
- PMID: 30855761
- DOI: 10.1056/NEJMc1900407
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply
Comment on
-
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.N Engl J Med. 2019 Mar 7;380(10):989-990. doi: 10.1056/NEJMc1900407. N Engl J Med. 2019. PMID: 30855760 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical